Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration StatementPRNewsWire • 10/31/23
Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone.Investors Business Daily • 10/23/23
Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep CongressPRNewsWire • 10/23/23
Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep CongressPRNewsWire • 10/10/23
Alkermes (ALKS) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 09/07/23
Alkermes Announces Launch of 6th Annual Alkermes Pathways Research Awards® ProgramPRNewsWire • 09/07/23
Alkermes shares surge after settlement with Teva on alcohol dependence treatmentMarket Watch • 08/30/23